Common Contracts

EX-1.1 2 d610765dex11.htm EX-1.1 Execution Version SELLAS Life Sciences Group, Inc. 6,845,000 Shares Common Stock ($0.0001 par value per share) and Pre-Funded Warrants to Purchase up to 4,675,000 Shares of Common Stock and Warrants to Purchase up to...

New York • May 5th, 2020

• Jurisdiction
  New York
• Filed
  May 5th, 2020

SELLAS Life Sciences Group, Inc. [●] Shares Common Stock ($0.0001 par value per share) and Pre-Funded Warrants to Purchase up to [●] Shares of Common Stock and Warrants to Purchase up to [●] Shares of Common Stock Underwriting Agreement

SELLAS Life Sciences Group, Inc. • June 13th, 2019 • Pharmaceutical preparations • New York

• Company
  SELLAS Life Sciences Group, Inc.
• Filed
  June 13th, 2019
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

SELLAS Life Sciences Group, Inc. 6,845,000 Shares Common Stock ($0.0001 par value per share) and Pre-Funded Warrants to Purchase up to 4,675,000 Shares of Common Stock and Warrants to Purchase up to 11,520,000 Shares of Common Stock Underwriting Agreement

SELLAS Life Sciences Group, Inc. • July 18th, 2018 • Pharmaceutical preparations • New York

• Company
  SELLAS Life Sciences Group, Inc.
• Filed
  July 18th, 2018
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

SELLAS Life Sciences Group, Inc., a corporation organized under the laws of Delaware (including any predecessor entities, the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, (i) an aggregate of 6,845,000 shares of common stock, $0.0001 par value per share (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Shares”), (ii) pre-funded warrants to purchase up to an aggregate of 4,675,000 shares of Common Stock (the “Pre-Funded Warrants”) at an exercise price of $0.0001 per share and (iii) warrants of the Company to purchase up to an aggregate of

SELLAS Life Sciences Group, Inc. Shares Common Stock ($0.0001 par value per share) and Pre-Funded Warrants to Purchase Shares of Common Stock and Warrants to Purchase Shares of Common Stock Underwriting Agreement

SELLAS Life Sciences Group, Inc. • July 11th, 2018 • Pharmaceutical preparations • New York

• Company
  SELLAS Life Sciences Group, Inc.
• Filed
  July 11th, 2018
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

SELLAS Life Sciences Group, Inc., a corporation organized under the laws of Delaware (including any predecessor entities, the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, (i) an aggregate of shares of common stock, $0.0001 par value per share (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Shares”), (ii) pre-funded warrants to purchase up to an aggregate of shares of Common Stock (the “Pre-Funded Warrants”) at an exercise price of $0.01 per share and (iii) warrants of the Company to purchase an aggregate